Latest filing published 02 Jun 2026 for NeoVolta Inc., €74k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +9.2%Entry US$1.95 · Close 22 Oct 2026 US$2.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steve Bond: trading record in brief
Filings by Steve Bond span 2 companies, the busiest being NeoVolta Inc. and Rapid Therapeutic Science Laboratories, Inc. The record holds 3 filings, for trades running from 29 January 2018 to 1 June 2026.
Every open-market trade on record is a purchase: 1 purchase worth €74k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 1 option exercise. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 2 June 2026: an open-market purchase of €74k, in NeoVolta Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Steve Bond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,000 shares@ US$1.9913100.0% of flowCommon StockSEC:0001683168-26-004456:0Canonical exit: 30 Aug 2026 (T+90)
- 250,000 sharesCommon StockSEC:0001683168-23-000033:0
- 250,000 shares0Common StockSEC:0001393905-18-000069:0
3 of 3 declarations